Latest News and Press Releases
Want to stay updated on the latest news?
-
CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at AUA
-
IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the AACR Annual Meeting
-
TARA-002 demonstrates 100% complete response rate at any time and 67% 12-month landmark complete response rate in BCG-Unresponsive patientsTARA-002 demonstrates 76% complete response rate at any time...
-
OXNARD, California, April 25, 2025 (GLOBE NEWSWIRE) -- Mission Produce, Inc. (NASDAQ: AVO) (“Mission” o "la Empresa”) un líder mundial en abastecimiento, producción y distribución de aguacates Hass...
-
SAN DIEGO, April 25, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic...
-
17 Education & Technology Group Inc. Files Its Annual Report on Form 20-F
-
FLORHAM PARK, N.J., April 25, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a cellular and regenerative medicine company, today announced that Nasdaq has...
-
GUANGZHOU, China, April 25, 2025 (GLOBE NEWSWIRE) -- AIFU Inc. (Nasdaq: AIFU) (the “Company” or “AIFU”), a leading AI-driven independent financial services platform in China, today announced that it...
-
ABU DHABI, United Arab Emirates, April 25, 2025 (GLOBE NEWSWIRE) -- NIP Group Inc. (“NIPG” or the “Company”) (NASDAQ: NIPG), a leading digital entertainment company, today announced that it plans to...
-
Palm Beach, FL, April 25, 2025 (GLOBE NEWSWIRE) -- New Providence Acquisition Corp. III (the “Company”) announced today the closing of its initial public offering of 30,015,000 units, which includes...